as on January 1, 2026 at 4:01 pm IST
Day's Low
Day's High
0.36%
Downside
4.52%
Upside
52 Week's Low
52 Week's High
5.64%
Downside
54.40%
Upside
as on January 1, 2026 at 4:01 pm IST
Market Cap
₹807.00 Cr
Return on Equity (ROE)
13.41
PE Ratio (TTM)
0Return on capital employed (ROCE)
17.15
Beta (LTM)
1.01
P/B Ratio
2.29
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-49.4
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Anuh Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 807.00 | -8.47% | 0.00 | 47 | 661 | |
| NA | 73.98 | -5.62% | 0.00 | 4 | 61 | |
| NA | 726.36 | 1.67% | 0.62 | 38 | 629 | |
| NA | 12.95 | -7.88% | 0.00 | NA | 51 | |
| BUY | 8,298.77 | 0.43% | 0.72 | 3,597 | 4,565 |
Get share price movements and forecasts by analysts on Anuh Pharma.
Source: S&P Global Market Intelligence
Search interest for Anuh Pharma Ltd Stock has increased by 101% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:101% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Anuh Pharma.
Anuh Pharma Ltd’s net profit fell -49.4% since last year same period to ₹7.61Cr in the Q2 2025-2026. On a quarterly growth basis, Anuh Pharma Ltd has generated -8.31% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Anuh Pharma Ltd has declared dividend of ₹1.50 per share on 23 May 2025 - translating a dividend yield of 1.86%.
Read More about DividendsCheck stock indices that include Anuh Pharma.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Up
![]()
Promoters have increased holdings from 69.92% to 71.82% in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 12.6% return, outperforming this stock by 42.9%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 148.6% return, outperforming this stock by 159.2%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 0.03% to 0.00% in Sep 2025 quarter
Price Dip
![]()
In the last 6 months, ANUHPHR stock has moved down by -25.1%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 30.06% to 28.18% in Sep 2025 quarter
| Organisation | Anuh Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Jasvantlal Shah |
| E-voting on shares | Click here to vote |
Anuh Pharma share price today stands at ₹78.69 as on at the close of the market. Anuh Pharma share today touched a day high of ₹82.25 and a low of ₹78.41.
Anuh Pharma touched a 52 week high of ₹121.5 and a 52 week low of ₹74.25. Anuh Pharma share price today i.e. is closed at ₹78.69, which is -35.23% down from its 52 week high and 5.98% up from its 52 week low.
Anuh Pharma market capitalisation is ₹807.00 Cr as on .
To buy Anuh Pharma shares, you need to follow these steps:
Anuh Pharma trading volume is 30.34K as on . This means that 30.34K shares of Anuh Pharma were bought and sold on the stock market during today's trading session.